Cargando…

Regional Cerebellar Volume Loss Predicts Future Disability in Multiple Sclerosis Patients

Cerebellar symptoms in multiple sclerosis (MS) are well described; however, the exact contribution of cerebellar damage to MS disability has not been fully explored. Longer-term observational periods are necessary to better understand the dynamics of pathological changes within the cerebellum and th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parmar, Katrin, Fonov, Vladimir S., Naegelin, Yvonne, Amann, Michael, Wuerfel, Jens, Collins, D. Louis, Gaetano, Laura, Magon, Stefano, Sprenger, Till, Kappos, Ludwig, Granziera, Cristina, Tsagkas, Charidimos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325849/ https://www.ncbi.nlm.nih.gov/pubmed/34417983 http://dx.doi.org/10.1007/s12311-021-01312-0

Ejemplares similares

Central nervous system atrophy predicts future dynamics of disability progression in a real‐world multiple sclerosis cohort
por: Tsagkas, Charidimos, et al.
Publicado: (2021)

Longitudinal changes of deep gray matter shape in multiple sclerosis
por: Tsagkas, Charidimos, et al.
Publicado: (2022)

Longitudinal patterns of cortical thinning in multiple sclerosis
por: Tsagkas, Charidimos, et al.
Publicado: (2020)

Classification of multiple sclerosis based on patterns of CNS regional atrophy covariance
por: Tsagkas, Charidimos, et al.
Publicado: (2021)

Cerebellar Abnormalities Contribute to Disability Including Cognitive Impairment in Multiple Sclerosis
por: Weier, Katrin, et al.
Publicado: (2014)

Levels of brain‐derived neurotrophic factor in patients with multiple sclerosis
por: Naegelin, Yvonne, et al.
Publicado: (2020)

Additive and interaction effects of working memory and motor sequence training on brain functional connectivity
por: Zuber, Priska, et al.
Publicado: (2021)

Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high‐dose pharmaceutical‐grade biotin (MD1003)
por: Collongues, Nicolas, et al.
Publicado: (2020)

Association of brain volume loss and long-term disability outcomes in patients with multiple sclerosis treated with teriflunomide
por: Sprenger, Till, et al.
Publicado: (2019)

White matter lesion filling improves the accuracy of cortical thickness measurements in multiple sclerosis patients: a longitudinal study
por: Magon, Stefano, et al.
Publicado: (2014)

White matter lesion location correlates with disability in relapsing multiple sclerosis
por: Gaetano, Laura, et al.
Publicado: (2020)

Brain atrophy measurement over a MRI scanner change in multiple sclerosis
por: Sinnecker, Tim, et al.
Publicado: (2022)

A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression
por: Nakamura, Yuri, et al.
Publicado: (2018)

Effects of teriflunomide treatment on cognitive performance and brain volume in patients with relapsing multiple sclerosis: Post hoc analysis of the TEMSO core and extension studies
por: Sprenger, Till, et al.
Publicado: (2022)

Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis
por: Cerdá-Fuertes, Nuria, et al.
Publicado: (2023)

Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis
por: Cagol, Alessandro, et al.
Publicado: (2023)

Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder: A Retrospective, Cross-sectional Analysis
por: Müller, Jannis, et al.
Publicado: (2022)

Fluid and White Matter Suppression: New Sensitive 3 T Magnetic Resonance Imaging Contrasts for Cortical Lesion Detection in Multiple Sclerosis
por: Müller, Jannis, et al.
Publicado: (2022)

Hepatitis E virus infections in patients with MS on oral disease-modifying treatment
por: Diebold, Martin, et al.
Publicado: (2019)

Leptomeningeal enhancement in multiple sclerosis and other neurological diseases: A systematic review and Meta-Analysis
por: Ineichen, Benjamin V., et al.
Publicado: (2022)

Practice Effects of Mobile Tests of Cognition, Dexterity, and Mobility on Patients With Multiple Sclerosis: Data Analysis of a Smartphone-Based Observational Study
por: Woelfle, Tim, et al.
Publicado: (2021)

Wearable Sensor Technologies to Assess Motor Functions in People With Multiple Sclerosis: Systematic Scoping Review and Perspective
por: Woelfle, Tim, et al.
Publicado: (2023)

Laminar analysis of the cerebellar cortex shows widespread damage in early MS patients: A pilot study at 7T MRI
por: Galbusera, Riccardo, et al.
Publicado: (2020)

Efficacy and Safety of Fingolimod in an Unselected Patient Population
por: Rasenack, Maria, et al.
Publicado: (2016)

Ocrelizumab reduces thalamic volume loss in patients with RMS and PPMS
por: Arnold, Douglas L, et al.
Publicado: (2022)

Death Anxiety and Attitudes towards Death in Patients with Multiple Sclerosis: An Exploratory Study
por: Francalancia, Jara, et al.
Publicado: (2021)

Fingolimod in children with Rett syndrome: the FINGORETT study
por: Naegelin, Yvonne, et al.
Publicado: (2021)

Addendum to “A white matter lesion-filling approach to improve braintissue volume measurements” [NeuroImage Clin. vol. 6, 2014, pages 86–92]
por: Magon, Stefano, et al.
Publicado: (2014)

Assessment of cognitive performance in multiple sclerosis using smartphone-based training games: a feasibility study
por: Pless, Silvan, et al.
Publicado: (2023)

Improved Characterization of Visual Evoked Potentials in Multiple Sclerosis by Topographic Analysis
por: Hardmeier, Martin, et al.
Publicado: (2013)

Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis
por: Radue, Ernst-Wilhelm, et al.
Publicado: (2015)

Subcortical brain segmentation of two dimensional T1-weighted data sets with FMRIB's Integrated Registration and Segmentation Tool (FIRST)
por: Amann, Michael, et al.
Publicado: (2014)

Reliability and acceptance of dreaMS, a software application for people with multiple sclerosis: a feasibility study
por: Woelfle, Tim, et al.
Publicado: (2022)

Personalized maps of T1 relaxometry abnormalities provide correlates of disability in multiple sclerosis patients
por: Chen, Xinjie, et al.
Publicado: (2023)

Individual Assessment of Brain Tissue Changes in MS and the Effect of Focal Lesions on Short-Term Focal Atrophy Development in MS: A Voxel-Guided Morphometry Study
por: Fox, Jan, et al.
Publicado: (2016)

Improving Accuracy of Brainstem MRI Volumetry: Effects of Age and Sex, and Normalization Strategies
por: Sander, Laura, et al.
Publicado: (2020)

Growth differentiation factor 15 is increased in stable MS
por: Amstad, Andrea, et al.
Publicado: (2020)

Measuring and Validating the Levels of Brain-Derived Neurotrophic Factor in Human Serum
por: Naegelin, Yvonne, et al.
Publicado: (2018)

Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis
por: Kappos, Ludwig, et al.
Publicado: (2015)

A comparative assessment of myelin-sensitive measures in multiple sclerosis patients and healthy subjects
por: Rahmanzadeh, Reza, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7flba38ta3pgog0nvapbo3qloc